- January 21, 2025
Yale Cancer Center Experts Lead National Roundtables
- January 20, 2025
Dr. Monica Valero on Yale Cancer Answers: Advancing Breast Cancer Care for Hispanic Women
- January 17, 2025Source: Nature
Biological and Clinical Significance of Tumor-Infiltrating Lymphocytes in the Era of Immunotherapy: A Multidimensional Approach
- January 17, 2025Source: NBC Connecticut
Cancer burden shifting from men to women in the U.S.
- January 16, 2025Source: The New York Times
Breast Cancer Rates Climb Among Younger Women
- January 16, 2025
Smilow Shares- Chop & Chat with Max and Nat: Fighting Cancer as a Family
- January 16, 2025Source: Yale News
Multi-target Approach Counters Tumor Growth in Several Cancers
- January 15, 2025Source: OncLive
Commentary: Emerging HER2-Directed Agents May Address Resistance to SOC Regimens in Pretreated HER2+ Breast Cancer
Yale Cancer Center
Yale Cancer Center combines a tradition of innovative cancer treatment and quality care for our patients. A National Cancer Institute (NCI) designated comprehensive cancer center for 50 years, Yale Cancer Center is one of only 57 such Centers in the nation. Yale Cancer Center is a collaboration between nationally and internationally renowned scientists and physicians at Yale School of Medicine and Smilow Cancer Hospital. This partnership enables the Center to provide the best approaches for prevention, detection, diagnosis, and treatment for cancer.
Choosing a comprehensive cancer center for your care can have profound implications for your treatment...
In the fight against cancer, Yale has been at the forefront of understanding the fundamental mechanisms of cancer biology and in developing effective therapies for cancer treatment.
Search Yale Cancer Center's Clinical Trials
Clinical trials are currently offered to our patients in all disease areas, including Phase I clinical trials for advanced and metastatic disease.